T0	Participants 71 124	patients with human immunodeficiency virus infection.
T1	Participants 220 263	human immunodeficiency virus type 1 (HIV-1)
T2	Participants 571 674	12 HIV-infected patients (mean [+/- standard deviation] CD4+ cell count, 304 +/- 213/mm3) were enrolled